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Abstract
Many exome sequencing studies of Mendelian disorders fail to optimally exploit family information. Classical
genetic linkage analysis is an effective method for eliminating a large fraction of the candidate causal variants
discovered, even in small families that lack a unique linkage peak. We demonstrate that accurate genetic linkage
mapping can be performed using SNP genotypes extracted from exome data, removing the need for separate
array-based genotyping. We provide software to facilitate such analyses.
Background
Whole exome sequencing (WES) has recently become a
popular strategy for discovering potential causal variants
in individuals with inherited Mendelian disorders, pro-
viding a cost- effective, fast-track approach to variant
discovery. However, a typical human genome differs
from the reference genome at over 10,000 potentially
functional sites [1]; identifying the disease-causing muta-
tion among this plethora of variants can be a significant
challenge. For this reason, exome sequencing is often
preceded by genetic linkage analysis, which allows var-
iants outside of linkage peaks to be excluded. The link-
age peaks delineate tracts of identity by descent sharing
that match the proposed genetic model. This combina-
tion strategy has been successfully used to identify var-
iants causing autosomal dominant [2-4] and recessive
[5-11] diseases, as well as those affecting quantitative
traits [12-14]. Linkage analysis has also been used in
conjunction with whole genome sequencing (WGS) [15].
Other WES studies have not performed formal linkage
analysis, but have nonetheless considered inheritance
information, such as searching for large regions of
homozygosity shared by affected family members using
genotypes obtained from genotyping arrays [16-18] or
exome data [19,20]. This method does not incorporate
genetic map or allele frequency information, which
could help to eliminate regions from consideration, and
is applicable only to recessive diseases resulting from
consanguinity. Recently, it has been suggested that iden-
tity by descent regions be identified from exome data
using a non-homogeneous hidden Markov model
(HMM), allowing variants outside these regions to be
eliminated [21,22]. This method incorporates genetic
map information but not allele frequency information
and requires a strict genetic model (recessive and fully
penetrant) and sampling scheme (exomes of two or
more affected siblings must be sequenced). It would be
suboptimal for use with diseases resulting from consan-
guinity, for which filtering by homozygosity by descent
would be more effective than filtering by identity by des-
cent. Finally, several WES studies have been published
that make no use of inheritance information whatsoever,
despite the fact that DNA from other informative family
members was available [23-31].
Classical linkage analysis using the multipoint Lander-
Green algorithm [32], which is a HMM, incorporates
genetic map and allele frequency information and allows
for great flexibility in the disease model. Unlike the
methods just mentioned, linkage analysis allows domi-
nant, recessive or X-linked inheritance models, as well
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lysis and formal haplotype inference. There are few con-
straints upon the sampling design, with unaffected
individuals able to contribute information to parametric
linkage analyses. The Lander-Green algorithm has pro-
duced many important linkage results, which have facili-
tated the identification of the underlying disease-causing
mutations.
We investigated whether linkage analysis using the
Lander-Green algorithm could be performed using gen-
otypes inferred from WES data, removing the need for
the array-based genotyping step [33]. We inferred geno-
types at the location of HapMap Phase II SNPs, [34] as
this resource provides comprehensive annotation,
including the population allele frequencies and genetic
map positions required for linkage analysis. We adapted
our existing software [35] to extract HapMap Phase II
SNP genotypes from WES data and format them for
linkage analysis.
We anticipated two potential disadvantages to this
approach. Firstly, exome capture only targets exonic
SNPs, resulting in gaps in marker coverage outside of
exons. Secondly, genotypes obtained using massively
parallel sequencing (MPS) technologies such as WES
tend to have a higher error rate than those obtained
from genotyping arrays [36]. The use of erroneous geno-
types in linkage analyses may reduce power to detect
linkage peaks or result in false positive linkage peaks
[37].
We compared the results of linkage analysis using
array-based and exome genotypes for three families with
different neurological disorders showing Mendelian
inheritance (Figure 1). We sequenced the exomes of two
affected siblings from family M, an Anglo-Saxon ances-
try family showing autosomal dominant inheritance.
The exome of a single affected individual, the offspring
of first cousins, from Iranian family A was sequenced, as
was the exome of a single affected individual, the off-
spring of parents thought to be first cousins once
removed, from the Pakistani family T. Families A and T
showed recessive inheritance. Due to the consanguinity
present in these families, we can perform linkage analy-
sis using genotypes from a single affected individual, a
method known as homozygosity mapping [33].
Results and discussion
Exome sequencing coverage of HapMap Phase II SNPs
Allele frequencies and genetic map positions were avail-
able for 3,269,163 HapMap Phase II SNPs that could be
translated to UCSC hg19 physical coordinates. The Illu-
mina TruSeq platform used for exome capture targeted
61,647 of these SNPs (1.89%). After discarding indels
and SNPs whose alleles did not match the HapMap
annotations, a median 56,931 (92.3%) of targeted SNPs
were covered by at least five high-quality reads (Table
1). A median of 64,065 untargeted HapMap Phase II
SNPs were covered by at least five reads; a median 78%
of these untargeted SNPs were found to lie within 200
bp of a targeted feature, comprising a median 57% of all
untargeted HapMap SNPs within 200 bp of a targeted
feature.
In total, we obtained a minimum of 117,158 and a
maximum of 133,072 SNP genotypes from the four
exomes. The array-based genotyping interrogated
598,821 genotypes for A-7 and T-1 (Illumina Infinium
HumanHap610W-Quad BeadChip) and 731,306 geno-
types for M-3 and M-4 (Illumina OmniExpress Bead-
Chip). Table 2 compares the inter-marker distances
between exome genotypes for each sample to those for
the genotyping array. The exome genotypes have much
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Figure 1 Partial pedigrees for families A, T and M.
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ing arrays, with a smaller median value.
Optimization of genotype concordance
We inferred genotypes at the positions of SNPs located
on the genotyping array used for each individual so that
we could investigate genotype concordance between the
two technologies. We found that ambiguous (A/T or C/
G SNPs) comprised a high proportion of SNPs with dis-
cordant genotypes, despite being a small proportion of
SNPs overall. For example, for A-7 at coverage ≥ 5a n d
t = 0.5 (see below), 77% (346 of 450) of discordant SNPs
were ambiguous SNPs, while ambiguous SNPs com-
posed just 2.7% of all SNPs (820 of 30,279). Such SNPs
are prone to strand annotation errors, as the two alleles
are the same on both strands of the SNP. We therefore
discarded ambiguous SNPs, which left 29,459 to 52,892
SNPs available for comparison (Table 3).
Several popular genotype-calling algorithms for MPS
data require the prior probability of a heterozygous gen-
otype to be specified [38,39]. We investigated the effect
of varying this parameter, t, upon concordance of geno-
typing array and WES genotypes (given WES coverage ≥
5; Table 3). Increasing this value from the default 0.001
results in a modest improvement in the percentage of
WES genotypes being correctly classified, with most of
the improvement occurring between t =0 . 0 0 1a n dt =
0.05. The highest concordance is achieved at t =0 . 5 ,
where all four samples achieve 99.7% concordance, com-
pared to 98.7 to 98.9% concordance at the default t =
0.001.
We note that t = 0.5 may not be optimal for calling
SNP genotypes on haploid chromosomes. At t =0 . 5 ,t h e
male M-4 had five × chromosome genotypes erroneously
called as heterozygous out of 1,026 (0.49%), while the
male T-1 had one such call out of 635 genotypes (0.16%).
The same SNPs were not called as heterozygous by the
genotyping arrays. No heterozygous × chromosome calls
were observed at the default value of t = 0.001.
Linkage analysis and LOD score concordance
Prior to performing linkage analysis on exome and array
SNP genotypes, we selected one SNP per 0.3 cM to ensure
linkage equilibrium while retaining a set of SNPs dense
enough to effectively infer inheritance. The resulting sub-
sets of WES genotypes (Table 4) contained 8,016 to 8,402
SNPs with average heterozygosities of 0.40 or 0.41 among
the CEPH HapMap genotypes, obtained from Utah resi-
dents with ancestry from northern and western Europe
(CEU). The resulting subsets of array genotypes (Table 4)
contained more SNPs (12,173 to 12,243), with higher aver-
age heterozygosities (0.48 or 0.49).
Despite this difference, there was good agreement
between LOD scores achieved at linkage peaks using the
different sets of genotypes (Figure 2, Table 5). The med-
ian difference between the WES and array LOD scores
across positions where either achieved the maximum
score was close to zero for all three families (range
-0.0003 to -0.002). The differences had a 95% empirical
interval of (-0.572,0.092) for family A, with the other
two families achieving narrower intervals (Table 5).
Efficacy of filtering identified variants by location of
linkage peaks
If our genetic model is correct, then variants lying out-
side of linkage peaks cannot be the causal mutation and
can be discarded, thus reducing the number of candi-
date disease-causing variants. Table 6 lists the number
of nonsynonymous exonic variants (single nucleotide
variants or indels) identified in each exome, as well as
the number lying with linkage peaks identified using
WES genotypes. The percentage of variants eliminated
depends upon the power of the pedigree being studied:
81.2% of variants are eliminated for the dominant family
M, which is not very powerful; 94.5% of variants are
Table 1 Number of HapMap Phase II SNPs covered ≥ 5 by distance to targeted base
Distance to Number of SNPs (%) HapMap
targeted base M-3 M-4 A-7 T-1 Phase II (N)
0 bp 56,648 (91.9) 56,835 (92.2) 57,027 (92.5) 58,142 (94.3) 61,647
1 to 200 bp 50,077 (56.7) 50,805 (57.5) 46,144 (52.2) 57,923 (65.6) 88,349
> 200 bp 13,683 (0.4) 13,565 (0.4) 13,987 (0.4) 17,007 (0.5) 3,119,167
Total 120,408 (3.7) 121,205 (3.7) 117,158 (3.6) 133,072 (4.1) 3,269,163
The denominator for percentages is the total number of HapMap Phase II SNPs in that distance category.
Table 2 Intermarker distances for the two genotyping
arrays and for exome genotypes covered ≥ 5
Median 1st quartile 3rd quartile
Illumina OmniExpress 2,233 814 5,125
Illumina 610 2,744 1,019 6,027
M-3 1,853 236 11,390
M-4 1,830 235 11,260
A-7 1,943 240 12,000
T-1 1,647 227 10,210
Intermarker distances are in base pairs.
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while 99.43% of variants are eliminated for the more dis-
tantly consanguineous, recessive family T. Hence, link-
age analysis substantially reduces the fraction of variants
identified that are candidates for the disease-causing
variant of interest.
Conclusions
Linkage analysis is of great potential benefit to WES stu-
dies that aim to discover genetic variants resulting in
Mendelian disorders. As variants outside of linkage
peaks can be eliminated, it reduces the number of iden-
tified variants that need to be investigated further. Link-
age analysis of WES genotypes provides information
regarding the location of the disease locus to be
extracted from WES data even if the causal variant is
not captured, suggesting regions of interest that may be
targeted in follow-up studies. However, many such stu-
dies are being published that employ less sophisticated
substitutes for linkage analysis or do not consider
inheritance information at all. Anecdotal evidence sug-
gests that a substantial proportion of MPS studies of
individuals with Mendelian disorders fail to identify a
causal variant, though an exact number is not known
due to publication bias.
We describe how to extract HapMap Phase II SNP
genotypes from massively parallel sequencing data,
providing software to facilitate this process and generate
files ready to be analyzed by popular linkage programs.
Our method allows linkage analysis to be performed
without requiring genotyping arrays. The flexibility of
linkage analysis means that our method can be applied
to any disease model and a variety of sampling schemes,
unlike existing methods of considering inheritance infor-
mation for WES data. Linkage analysis incorporates
population allele frequencies and genetic map positions,
which allows superior identification of statistically unu-
sual sharing of haplotypes between affected individuals
in a family.
We demonstrate linkage using WES genotypes for
three small nuclear families - a dominant family from
which two exomes were sequenced and two consangui-
neous families from which a single exome was
sequenced. As these families are not very powerful for
linkage analysis, multiple linkage peaks with relatively
low LOD scores were identified. Nonetheless, discarding
variants outside of the linkage peaks eliminated between
81.2% and 99.43% of all nonsynonymous exonic variants
detected in these families. The number of variants
remaining could be reduced further by applying stan-
dard strategies, such as discarding known SNPs with
minor allele frequencies above a certain threshold. Our
work demonstrates the value of considering inheritance
information, even in very small families that may con-
sist, at the extreme, of a single inbred individual. As the
price of exome sequencing falls, it will become feasible
to sequence more individuals from each family, resulting
in fewer linkage peaks with higher LOD scores.
Exome capture using current technologies yields
large numbers of useful SNPs for linkage mapping.
Over half of all SNPs covered by five or more reads
were not targeted by the exome capture platform.
Approximately 78% of these captured untargeted SNPs
lay within 200 bp of a targeted feature. This reflects
the fact that fragment lengths typically exceed probe
lengths, resulting in flanking sequences at both ends of
Table 3 Increasing the prior heterozygous probability modestly improves concordance between exome and array
genotypes
t M-3 (N = 52,617) M-4 (N = 52,892) A-7 (N = 29,459) T-1 (N = 32,763)
0.00001 0.9737 0.9734 0.9698 0.9741
0.001 (default) 0.9882 0.9874 0.9865 0.9885
0.01 0.9927 0.9926 0.9918 0.9925
0.05 0.9951 0.9950 0.9942 0.9945
0.1 0.9958 0.9958 0.9950 0.9952
0.2 0.9968 0.9965 0.9958 0.9961
0.3 0.9971 0.9968 0.9961 0.9964
0.4 0.9973 0.9971 0.9964 0.9968
0.5 0.9974 0.9973 0.9965 0.9969
Proportion of SNPs where WES and genotyping array genotypes are concordant for the four exomes, for varying values of t (prior probability of a heterozygous
genotype). Conditional on coverage with ≥ 5 reads.
Table 4 Number and average heterozygosity of array and
WES SNPs selected for linkage analysis
M-3 and M-4 A-7 T-1
WES Array WES Array WES Array
SNPs available 114,681 677,144 117,158 593,638 133,071 587,680
SNPs selected 8,016 12,173 8,135 12,243 8,402 12,194
Average
heterozygosity
0.40 0.49 0.40 0.48 0.41 0.48
Average heterozygosity refers to the HapMap CEU population and not to the
individual being studied. For M-3 and M-4, ‘SNPs available’ is the number of
SNPs covered ≥ 5 in both individuals.
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serendipitous result is thatas u b s t a n t i a ln u m b e ro f
non-exonic SNPs become available, which can and
should be used for linkage analysis.
We found that setting the prior probability of hetero-
zygosity to 0.5 during genotype inference resulted in the
best concordance between WES and array genotypes.
The authors of the MAQ SNP model recommend using
t = 0.2 for inferring genotypes at known SNPs [38],
while the default value used to detect variants is t =
0.001. Our results highlight the need to tailor this para-
meter to the specific application, either genotyping or
rare variant detection. Although we anticipated WES
genotypes being less accurate than array genotypes, all
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Figure 2 Genome-wide comparison of LOD scores using array-based and WES-derived genotypes for families A, T and M.
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Page 5 of 9four samples achieved a high concordance of 99.7% for
SNPs covered by five or more reads at t = 0.5
We found that LOD scores obtained from WES geno-
types agreed well with those obtained from array geno-
types from the same individual(s) at the location of
linkage peaks, with the median difference in LOD score
zero to two or three decimal places for all three families.
This was despite the fact that the array-based genotype
sets used for analysis contained more markers and had
higher average heterozygosities than the corresponding
WES genotype sets, reflecting the fact that genotyping
arrays are designed to interrogate SNPs with relatively
high minor allele frequencies that are relatively evenly
spaced throughout the genome. By contrast, genotypes
extracted from WES data tend to be clustered around
exons, resulting in fewer and less heterozygous markers
after pruning to achieve linkage equilibrium. We con-
clude that if available, array-based genotypes from a
high resolution SNP array are preferable to WES geno-
types; but if not, linkage analysis of WES genotypes pro-
duces acceptable results.
Once WGS is more economical, we will be able to
perform linkage analysis using genotypes extracted from
WGS data, which will obviate the problem of gaps in
SNP coverage outside of exons. The software tools we
provide can accommodate WGS genotypes without
requiring modification. In the future, initiatives such as
the 1000 Genomes Project [1] may provide population-
specific allele frequencies for SNPs not currently
included in HapMap, further increasing the number of
SNPs available for analyses, as well as the number of
populations studied.
The classic Lander-Green algorithm requires markers
to be in linkage equilibrium [40]. Modeling linkage dis-
equilibrium would allow incorporation of all markers
without the need to select a subset of markers in
linkage equilibrium. This would allow linkage mapping
using distant relationships, such as distantly inbred
individuals who would share a sub-linkage (< 1 cM)
tract of DNA homozygous by descent. Methods that
incorporate linkage disequilibrium have already been
proposed, including a variable length HMM that can
be applied to detect distantly related individuals [41].
Further work is being targeted towards approximations
of distant relationships to connect sets of related pedi-
grees [42]. These methods will extract the maximum
information from MPS data from individuals with
inherited diseases.
We have integrated the relatively new field of MPS in
families with classical linkage analysis. Where feasible,
we strongly advocate the use of linkage mapping in
combination with MPS studies that aim to discover var-
iants causing Mendelian disorders. This approach does
not require purpose-built HMMs, but can utilize exist-
ing software implementations of the Lander-Green algo-
rithm. Where genotyping array genotypes are not
available, we recommend utilizing MPS data to their full
capacity by using MPS genotypes to perform linkage
analysis. This will reduce the number of candidate dis-
ease-causing variants that need to be evaluated further.
Should the causal variant not be identified by a WES
study, linkage analysis will highlight regions of the gen-
ome where targeted resequencing is most likely to iden-
tify this variant.
Materials and methods
Informed consent, DNA extraction and array-based
genotyping
Written informed consent was provided by the four par-
ticipants or their parents. Ethics approval was provided
by the Royal Children’s Hospital Research Ethics Com-
mittee (HREC reference number 28097) in Melbourne.
Genomic DNA was extracted from participants’ blood
samples using the Nucleon™ BACC Genomic DNA
Extraction Kit (GE Healthcare, Little Chalfont, Buckin-
ghamshire, England).
All four individuals were genotyped using Illumina
Infinium HumanHap610W-Quad BeadChip (A-7, T-1)
or OmniExpress (M-3, M-4) genotyping arrays (fee for
service, Australian Genome Research Facility, Mel-
bourne, Victoria, Australia). These arrays interrogate
Table 5 Distribution of LOD score differences (WES -
array) at linkage peaks
Family Median 2.5th centile 97.5th centile
A -0.0005 -0.572 0.092
T -0.002 -0.390 0.035
M -0.0003 -0.117 0.0034
Summary of differences at analysis positions where either the WES or the
array LOD scores reach their genome-wide maximum.
Table 6 Efficacy of variant elimination due to linkage peak filtering
Family Model Consanguinity Number of
linkage peaks
Max
LOD
Number of not
synonymous exonic
variants
Number of (%) not synonymous exonic
variants in linkage regions
A Recessive First cousin offspring 15 1.2 10,982 604 (5.50)
T Recessive First cousins once
removed offspring
5 1.51 11,353 65 (0.57)
M Dominant None 41 0.3 13,186 2,478 (18.79)
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Page 6 of 9598,821 and 731,306 SNPs respectively, with 342,956
markers in common. Genotype calls were generated
using version 6.3.0 of the GenCall algorithm implemen-
ted in Illumina BeadStudio. A GenCall score cutoff (no-
call threshold) of 0.15 was used.
Exome capture, sequencing and alignment
Target DNA for the four individuals was captured using
Illumina TruSeq, which is designed to capture a target
region of 62,085,286 bp (2.00% of the genome), and
sequenced using an Illumina HiSeq machine (fee for ser-
vice, Axeq Technologies, Rockville, MD, United States).
Individual T-1 was sequenced using one-quarter of a
flow cell lane while the other three individuals were
sequenced using one-eighth of a lane. Paired-end reads
of 110 bp were generated.
Reads were aligned to UCSC hg19 using Novoalign
version 2.07.05 [43]. Quality score recalibration was per-
formed during alignment, and reads that aligned to mul-
tiple locations were discarded. Following alignment,
presumed PCR duplicates were removed using MarkDu-
plicates.jar from Picard [44]. Table S1 in Additional file
1 shows the number of reads at each stage of proces-
sing, while Tables S2 and S3 in the same file show cov-
erage statistics for the four exomes.
WES genotype inference and linkage analysis
SNP genotypes were inferred from WES data using the
samtools mpileup and bcftools view commands from
release 916 of the SAMtools package [45], which infers
genotypes using a revised version of the MAQ SNP model
[38]. We required base quality and mapping quality ≥ 13.
SAMtools produces a variant call format (VCF) file, from
which we extracted genotypes using a Perl script.
These genotypes were formatted for linkage analysis
using a modified version of the Perl script linkdatagen.pl
[35] with an annotation file prepared for HapMap Phase
II SNPs. This script chose one SNP per 0.3 cM to be
used for analysis, with SNPs selected to maximize het-
erozygosity according to CEU HapMap genotypes [34].
Array-based genotypes were prepared for linkage analy-
sis in the same way, using annotation files for the appro-
priate array.
The two Perl scripts used to extract genotypes from
VCF files and format them for linkage analysis are freely
available on our website [46], as is the annotation file
for HapMap Phase II SNPs. Users may also download
VCF files containing WES SNP genotypes for the four
individuals described here (both for HapMap Phase II
and genotyping array SNPs), as well as files containing
genotyping array genotypes for comparison.
Multipoint parametric linkage analysis using WES and
array genotypes was performed using MERLIN [47]. A
population disease allele frequency of 0.00001 was
specified, along with a fully penetrant recessive (family
A, family T) or dominant (family M) genetic model.
LOD scores were estimated at positions spaced 0.3 cM
apart, and CEU allele frequencies were used.
WES variant detection
SAMtools mpileup/bcftools was also used to detect var-
iants from the reference sequence with the default set-
ting of t = 0.001. Variants were annotated by
ANNOVAR [48] using the UCSC Known Gene annota-
tion. For the purposes of filtering variants, linkage peaks
were defined as the intervals in which the genome-wide
maximum LOD score was obtained, plus 0.3 cM on
either side.
Additional material
Additional file 1: Supplementary tables.
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